QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price targ...

 trump-administration-review-targets-medical-supply-chain-vulnerabilities

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

Core News & Articles

Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target fro...

Core News & Articles

Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $63 to $66.

Core News & Articles

Baird analyst Vikram Kesavabhotla initiates coverage on Hinge Health (NYSE:HNGE) with a Neutral rating and announces Price T...

Core News & Articles

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $52 t...

Core News & Articles

JMP Securities analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and raises the price target ...

Core News & Articles

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $51 to $62.

Core News & Articles

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price targ...

Core News & Articles

Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $47 to $59.

Core News & Articles

B of A Securities analyst Brad Sills maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $42 to $64.

Core News & Articles

Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target fro...

Core News & Articles

Hinge Health (NYSE:HNGE) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.09 by 6...

Core News & Articles

Hinge Health (NYSE:HNGE) sees Q3 sales of $141.000 million-$143.000 million vs $129.141 million analyst estimate.

Core News & Articles

Hinge Health (NYSE:HNGE) sees FY2025 sales of $548.000 million-$552.000 million vs $512.089 million analyst estimate.

Core News & Articles

Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $48 to $55.

Core News & Articles

JMP Securities analyst Aaron Kimson initiates coverage on Hinge Health (NYSE:HNGE) with a Market Outperform rating and annou...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION